Independent Advisor Alliance Biogen Inc. Transaction History

Independent Advisor Alliance

$2.74 Billion
Q1 2024

A detailed history of Independent Advisor Alliance transactions in Biogen Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 9,343 shares of BIIB stock, worth $2.11 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

9,343

Previous 9,051 3.23%

Holding current value

$2.11 Million

Previous $2.34 Million 14.01%

% of portfolio

0.07%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $61,909 - $78,171	292 Added 3.23%	9,343 $2.01 Million
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $80,800 - $97,262	363 Added 4.18%	9,051 $2.34 Million
Q3 2023 Oct 24, 2023	BUY	$253.3 - $285.89 $345,754 - $390,239	1,365 Added 18.64%	8,688 $2.23 Million
Q2 2023 Jul 28, 2023	BUY	$275.25 - $318.06 $6,881 - $7,951	25 Added 0.34%	7,323 $2.09 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $1.87 Million - $2.13 Million	7,298 New	7,298 $2.03 Million

Q3 2022 Nov 04, 2022	BUY	$194.69 - $268.46 $61,132 - $84,296	314 Added 5.02%	6,570 $1.75 Million
Q2 2022 Aug 04, 2022	BUY	$187.54 - $223.02 $951,577 - $1.13 Million	5,074 Added 429.27%	6,256 $1.28 Million
Q1 2022 May 06, 2022	BUY	$193.77 - $244.14 $19,764 - $24,902	102 Added 9.44%	1,182 $249,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $71,654 - $92,086	-320 Reduced 22.86%	1,080 $259,000
Q3 2021 Nov 01, 2021	BUY	$282.99 - $369.05 $34,807 - $45,393	123 Added 9.63%	1,400 $396,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $6,475 - $10,367	-25 Reduced 1.92%	1,277 $442,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $5,344 - $6,261	-22 Reduced 1.66%	1,302 $364,000
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $89,070 - $134,072	377 Added 39.81%	1,324 $324,000
Q3 2020 Nov 04, 2020	BUY	$264.77 - $305.71 $250,737 - $289,507	947 New	947 $269,000
Q2 2020 Aug 06, 2020	SELL	$258.66 - $342.55 $164,766 - $218,204	-637 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $171,257 - $217,242	637 New	637 $202,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $224,333 - $247,279	-1,023 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $22,537 - $35,251	104 Added 11.32%	1,023 $242,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $106,944 - $135,456	-384 Reduced 29.47%	919 $277,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.02 Million - $1.33 Million	-3,460 Reduced 72.64%	1,303 $392,000
Q2 2018 Aug 08, 2018	BUY	$257.52 - $306.91 $934,540 - $1.11 Million	3,629 Added 320.02%	4,763 $1.33 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $193,016 - $272,989	-742 Reduced 39.55%	1,134 $304,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $254,110 - $284,623	826 Added 78.67%	1,876 $618,000
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $295,207 - $346,174	1,050	1,050 $346,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Biogen Inc. Transaction History